It has been reported that the expression of the membrane (MT1 and MT2) receptors of melatonin decreases in patients with colon cancer [22], but mainly in those with mutations in the p53 gene [23], although melatonin levels and the expression of nuclear (RORα) receptors do not change [22]. This evidence concerns the gene TP53 and colonic neoplasm.